Brief: Sygnis To Raise Capital To Buy TGR Biosciences

2Invest AG

19/03/2018 17:09

March 19 (Reuters) - SYGNIS AG  LIO1k.DE :
    * SYGNIS AG TO RAISE CAPITAL VIA A PRIVATE PLACEMENT OF NEW
SHARES
TO ACQUIRE TGR BIOSCIENCES
    * TO LAUNCH A PRIVATE PLACEMENT OF UP TO 4.7 MILLION NEW
SHARES TO
INSTITUTIONAL INVESTORS IN EUROPE
    * PRICE PER SHARE IS SET TO EUR 1.40
    * PLANS TO USE PROCEEDS FROM TRANSACTION FOR ACQUISITION OF
AUSTRALIAN RESEARCH REAGENTS COMPANY TGR BIOSCIENCES
    * ACQUISITION OF TGR BIOSCIENCES WAS PRICED AT A VALUE OF
EUR 10.4
MILLION
    * REACHED AGREEMENT WITH CURRENT MAJORITY SHAREHOLDERS OF
TARGET
COMPANY, REPRESENTING 78 PCT OF TOTAL VOTING RIGHTS

Source text for Eikon:  ID:nEQ9MvC4sa 
Further company coverage:  LIO1k.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))